Stargardt Disease Trial

Researchers in Southampton are opening up a new drug trial that potentially could lead to a prevention of sight loss for those with Stargardt’s disease. This trial is the first ever of its kind in the UK with the hospital being a part of a £5 million EU research funded project! There is some criteria to fit in order to partake in the study. The trial will take place over 14 months, participants will have to visit the hospital at least 11 times and have a documented first appearance of Stargardt’s disease before the age of 45. Please visit the website for more information as there is more criteria to fulfill in order to participate.

Newsletter Signup

To keep up to date with our news and activities,
please leave your details below

GDPR Compliance Please indicate your consent for Retina International to contact you via the email address listed for the purposes of general alerts and newsletters.